X4 Pharmaceuticals, Inc. (XFOR)
3.77
-0.10
(-2.58%)
USD |
NASDAQ |
Jan 14, 16:00
3.79
+0.02
(+0.53%)
After-Hours: 20:00
X4 Pharmaceuticals SG&A Expense (TTM): 51.28M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Adverum Biotechnologies, Inc. | 59.84M |
| Hims & Hers Health, Inc. | 1.147B |
| Recursion Pharmaceuticals, Inc. | 220.12M |
| Quantum-Si, Inc. | 48.78M |